Sam Beck1, Rachel J Errington2, Sara Gould3, Helen Winter4, Grace L Edmunds5, Matthew J Smalley6, Dave C Brodbelt7, Dan G O'Neill7. 1. VPG Histology (formerly Bridge), Horner Court, 637 Gloucester Road, Horfield, Bristol, BS7 0BJ, UK. 2. Division of Cancer and Genetics, School of Medicine, Academic Avenue, Cardiff University, Cardiff, CF62 3LF, UK. 3. Langford Veterinary Services, Langford House Langford, Bristol, BS40 5DU, UK. 4. Bristol Cancer Institute, Bristol, BS2 8ED, UK. 5. Bristol Veterinary School, Langford House, Langford, Bristol, BS40 5DU, UK. ge8793@bristol.ac.uk. 6. European Cancer Stem Cell Research Institute and School of Biosciences, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ, UK. 7. Pathobiology and Population Sciences, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts, AL9 7TA, UK.
Abstract
BACKGROUND: Osteosarcoma is an aggressive and painful bone neoplasm in dogs. Previous studies have reported epidemiological associations suggesting that large body mass, long bone length and the genetics of certain breeds including the Rottweiler are associated with elevated osteosarcoma risk. However, these studies were often limited by selection bias and confounding factors, and have rarely offered insights into breed-associated protection for osteosarcoma. The current study includes 1756 appendicular and axial osteosarcoma cases presenting to VPG Histology (Bristol, UK) compared against a control population of 905,211 dogs without osteosarcoma from primary care electronic patient records in the VetCompass™ dataset. METHODS AND STUDY DESIGN: Retrospective, case-control study. Multivariable logistic regression analysis explored associations between demographic risk factors (including breed, chondrodystrophy, age, sex/neuter status, skull-shape, and body mass) and osteosarcoma of all anatomical sites. RESULTS: We identified several breeds with increased and reduced odds of osteosarcoma. At highest risk were the Rottweiler and Great Dane, with > 10 times the odds of osteosarcoma compared with crossbreds, and the Rhodesian Ridgeback, which has not featured in previous lists of at-risk breeds for osteosarcoma, and had an odds ratio of 11.31 (95% confidence interval 7.37-17.35). Breeds at lowest risk of osteosarcoma (protected breeds) included the Bichon Frise, the French Bulldog and the Cavalier King Charles Spaniel, all with odd ratios of less than 0.30 compared with crossbreds. Body mass was strongly associated with osteosarcoma risk; dogs over 40 kg exhibited osteosarcoma odds of 45.44 (95% confidence interval 33.74-61.20) compared with dogs less than 10 kg. Chondrodystrophic breeds had an osteosarcoma odds ratio of 0.13 (95% confidence interval 0.11-0.16) compared with non-chondrodystrophic breeds. CONCLUSIONS: This study provides evidence of strong breed-associated osteosarcoma risk and protection, suggesting a genetic basis for osteosarcoma pathogenesis. It highlights that breeds selected for long legs/large body mass are generally overrepresented amongst at-risk breeds, whilst those selected for short leg length/small body mass are generally protected. These findings could inform genetic studies to identify osteosarcoma risk alleles in canines and humans; as well as increasing awareness amongst veterinarians and owners, resulting in improved breeding practices and clinical management of osteosarcoma in dogs.
BACKGROUND:Osteosarcoma is an aggressive and painful bone neoplasm in dogs. Previous studies have reported epidemiological associations suggesting that large body mass, long bone length and the genetics of certain breeds including the Rottweiler are associated with elevated osteosarcoma risk. However, these studies were often limited by selection bias and confounding factors, and have rarely offered insights into breed-associated protection for osteosarcoma. The current study includes 1756 appendicular and axial osteosarcoma cases presenting to VPG Histology (Bristol, UK) compared against a control population of 905,211 dogs without osteosarcoma from primary care electronic patient records in the VetCompass™ dataset. METHODS AND STUDY DESIGN: Retrospective, case-control study. Multivariable logistic regression analysis explored associations between demographic risk factors (including breed, chondrodystrophy, age, sex/neuter status, skull-shape, and body mass) and osteosarcoma of all anatomical sites. RESULTS: We identified several breeds with increased and reduced odds of osteosarcoma. At highest risk were the Rottweiler and Great Dane, with > 10 times the odds of osteosarcoma compared with crossbreds, and the Rhodesian Ridgeback, which has not featured in previous lists of at-risk breeds for osteosarcoma, and had an odds ratio of 11.31 (95% confidence interval 7.37-17.35). Breeds at lowest risk of osteosarcoma (protected breeds) included the Bichon Frise, the French Bulldog and the Cavalier King Charles Spaniel, all with odd ratios of less than 0.30 compared with crossbreds. Body mass was strongly associated with osteosarcoma risk; dogs over 40 kg exhibited osteosarcoma odds of 45.44 (95% confidence interval 33.74-61.20) compared with dogs less than 10 kg. Chondrodystrophic breeds had an osteosarcoma odds ratio of 0.13 (95% confidence interval 0.11-0.16) compared with non-chondrodystrophic breeds. CONCLUSIONS: This study provides evidence of strong breed-associated osteosarcoma risk and protection, suggesting a genetic basis for osteosarcoma pathogenesis. It highlights that breeds selected for long legs/large body mass are generally overrepresented amongst at-risk breeds, whilst those selected for short leg length/small body mass are generally protected. These findings could inform genetic studies to identify osteosarcoma risk alleles in canines and humans; as well as increasing awareness amongst veterinarians and owners, resulting in improved breeding practices and clinical management of osteosarcoma in dogs.
Authors: William T N Culp; Francisco Olea-Popelka; Jennifer Sefton; Charles F Aldridge; Stephen J Withrow; Mary H Lafferty; Robert B Rebhun; Michael S Kent; Nicole Ehrhart Journal: J Am Vet Med Assoc Date: 2014-11-15 Impact factor: 1.936
Authors: Megan E Aanstoos; Daniel P Regan; Ruth J Rose; Laura S Chubb; Nicole P Ehrhart Journal: Clin Orthop Relat Res Date: 2016-03 Impact factor: 4.176
Authors: Elinor K Karlsson; Snaevar Sigurdsson; Emma Ivansson; Rachael Thomas; Ingegerd Elvers; Jason Wright; Cedric Howald; Noriko Tonomura; Michele Perloski; Ross Swofford; Tara Biagi; Sarah Fryc; Nathan Anderson; Celine Courtay-Cahen; Lisa Youell; Sally L Ricketts; Sarah Mandlebaum; Patricio Rivera; Henrik von Euler; William C Kisseberth; Cheryl A London; Eric S Lander; Guillermo Couto; Kenine Comstock; Mike P Starkey; Jaime F Modiano; Matthew Breen; Kerstin Lindblad-Toh Journal: Genome Biol Date: 2013-12-12 Impact factor: 13.583
Authors: Siobhan Simpson; Mark David Dunning; Simone de Brot; Llorenç Grau-Roma; Nigel Patrick Mongan; Catrin Sian Rutland Journal: Acta Vet Scand Date: 2017-10-24 Impact factor: 1.695
Authors: Claire L Brand; Dan G O'Neill; Zoe Belshaw; Camilla L Pegram; Kim B Stevens; Rowena M A Packer Journal: Animals (Basel) Date: 2022-03-02 Impact factor: 2.752
Authors: Katia Pinello; Isabel Pires; Ana Filipa Castro; Paulo Tiago Carvalho; Andreia Santos; Augusto de Matos; Felisbina Queiroga; Ana Canadas-Sousa; Patrícia Dias-Pereira; José Catarino; Pedro Faísca; Sandra Branco; Cristiana Lopes; Filipa Marcos; Maria C Peleteiro; Hugo Pissarra; Pedro Ruivo; Rui Magalhães; Milton Severo; João Niza-Ribeiro Journal: Vet Sci Date: 2022-03-31
Authors: Anna Letko; Katie M Minor; Elaine M Norton; Voichita D Marinescu; Michaela Drögemüller; Emma Ivansson; Kate Megquier; Hyun Ji Noh; Mike Starkey; Steven G Friedenberg; Kerstin Lindblad-Toh; James R Mickelson; Cord Drögemüller Journal: Genes (Basel) Date: 2021-12-09 Impact factor: 4.096